APA (7th ed.) Citation

Agrawal, P. K., & Garg, R. (2026). Anti-Obesity Drugs: The Rising Significance of GLP-1Agonist, Tirzepatide. Journal of Mid-life Health, 17(2), 206. https://doi.org/10.4103/jmh.jmh_259_25

Chicago Style (17th ed.) Citation

Agrawal, Prabhat Kumar, and Ruchika Garg. "Anti-Obesity Drugs: The Rising Significance of GLP-1Agonist, Tirzepatide." Journal of Mid-life Health 17, no. 2 (2026): 206. https://doi.org/10.4103/jmh.jmh_259_25.

MLA (9th ed.) Citation

Agrawal, Prabhat Kumar, and Ruchika Garg. "Anti-Obesity Drugs: The Rising Significance of GLP-1Agonist, Tirzepatide." Journal of Mid-life Health, vol. 17, no. 2, 2026, p. 206, https://doi.org/10.4103/jmh.jmh_259_25.